CNS Partnerships Axxam has secured CNS focused collaborations with Lundbeck and Momentum Biotechnologies, demonstrating credibility in neurodrug discovery and the ability to scale partnerships to larger programs.

Sustainable Cross Industry Axxam is positioned to win business from crop protection, animal health, and consumer goods companies seeking sustainable discovery and access to natural and synthetic compound libraries.

AI Enabled Discovery Integration with an AI driven platform moves digital predictions to lab validation, enabling faster decision making and a compelling value proposition for clients seeking speed and accuracy in drug discovery.

Growth Leadership Leadership expansion with new chief operating officer and chief scientific officer signals readiness to scale projects and deliver larger, more complex discovery programs.

European Footprint Milan based firm with EU exposure and partnerships, a strong entry point for Europe focused collaborations with mid sized pharma and biotech players seeking integrated discovery and compound management.